Pixelgen Technologies Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
44
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$15.5M
- Investors
-
6
Pixelgen Technologies General Information
Description
Developer of bio-analytical tools designed for biomedical research and diagnostics. The company develops novel analytical methods and products capable of seeing the inner workings of life and delivering these to researchers and drug developers, enabling clients to gain new insights into biomedicine and ultimately improve health.
Contact Information
Website
www.pixelgen.comCorporate Office
- Hagaplan 4
- 113 68 Stockholm
- Sweden
Corporate Office
- Hagaplan 4
- 113 68 Stockholm
- Sweden
Pixelgen Technologies Timeline
Pixelgen Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 20-Aug-2026 | $15.5M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 30-Jun-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 09-Oct-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 07-Dec-2022 | $5.89M | $7.24M | Completed | Generating Revenue | |
| 1. Seed Round | 31-Dec-2021 | $1.35M | $1.35M | Completed | Startup |
Pixelgen Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Seed | 68,500 | $16.16 | $16.16 | 1x | $16.16 | 22.91% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pixelgen Technologies Patents
Pixelgen Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4829046-A1 | Method for spatial mapping of cell targets | Pending | 25-Jan-2024 | ||
| WO-2025158200-A1 | Method for spatial mapping of cell targets | Pending | 25-Jan-2024 | ||
| WO-2024241162-A1 | Peptide for site-specific antibody conjugation and method of use | Inactive | 25-May-2023 | ||
| EP-4627107-A1 | Gap-fill ligation and primer extension reactions employing exonuclease-resistant or capture moiety means | Pending | 18-Jan-2023 | ||
| WO-2024154075-A1 | Gap-fill ligation and primer extension reactions employing exonuclease-resistant or capture moiety means | Inactive | 18-Jan-2023 | C12Q1/6804 |
Pixelgen Technologies Signals
Pixelgen Technologies Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Flat Capital | Venture Capital | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Industrifonden | Venture Capital | Minority | ||
| Colibri Ventures | Venture Capital | Minority | ||
| Fibonacci Growth Capital | PE/Buyout | Minority |
Pixelgen Technologies FAQs
-
When was Pixelgen Technologies founded?
Pixelgen Technologies was founded in 2020.
-
Where is Pixelgen Technologies headquartered?
Pixelgen Technologies is headquartered in Stockholm, Sweden.
-
What is the size of Pixelgen Technologies?
Pixelgen Technologies has 44 total employees.
-
What industry is Pixelgen Technologies in?
Pixelgen Technologies’s primary industry is Discovery Tools (Healthcare).
-
Is Pixelgen Technologies a private or public company?
Pixelgen Technologies is a Private company.
-
What is Pixelgen Technologies’s current revenue?
The current revenue for Pixelgen Technologies is .
-
How much funding has Pixelgen Technologies raised over time?
Pixelgen Technologies has raised $44.3M.
-
Who are Pixelgen Technologies’s investors?
Flat Capital, European Innovation Council, Industrifonden, Colibri Ventures, and Fibonacci Growth Capital are 5 of 6 investors who have invested in Pixelgen Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process